nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—ABCB1—melanoma	0.285	1	CbGaD
Buspirone—CYP3A4—Temozolomide—melanoma	0.0861	0.189	CbGbCtD
Buspirone—CYP2D6—Vemurafenib—melanoma	0.0742	0.163	CbGbCtD
Buspirone—CYP3A7—Docetaxel—melanoma	0.0553	0.122	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0553	0.122	CbGbCtD
Buspirone—ABCB1—Dactinomycin—melanoma	0.0523	0.115	CbGbCtD
Buspirone—CYP3A4—Vemurafenib—melanoma	0.0472	0.104	CbGbCtD
Buspirone—CYP3A5—Docetaxel—melanoma	0.0415	0.0912	CbGbCtD
Buspirone—ABCB1—Docetaxel—melanoma	0.027	0.0594	CbGbCtD
Buspirone—CYP3A4—Docetaxel—melanoma	0.0162	0.0356	CbGbCtD
Buspirone—Face oedema—Carmustine—melanoma	0.000875	0.00552	CcSEcCtD
Buspirone—Affect lability—Temozolomide—melanoma	0.000862	0.00544	CcSEcCtD
Buspirone—Ataxia—Carmustine—melanoma	0.000853	0.00538	CcSEcCtD
Buspirone—Face oedema—Temozolomide—melanoma	0.000846	0.00533	CcSEcCtD
Buspirone—Mood swings—Temozolomide—melanoma	0.00083	0.00523	CcSEcCtD
Buspirone—Ataxia—Temozolomide—melanoma	0.000824	0.00519	CcSEcCtD
Buspirone—Weight decreased—Bleomycin—melanoma	0.000812	0.00512	CcSEcCtD
Buspirone—Dry skin—Temozolomide—melanoma	0.000803	0.00506	CcSEcCtD
Buspirone—Muscular weakness—Carmustine—melanoma	0.0008	0.00504	CcSEcCtD
Buspirone—Acute coronary syndrome—Bleomycin—melanoma	0.000789	0.00498	CcSEcCtD
Buspirone—Hypotension—Vemurafenib—melanoma	0.000787	0.00496	CcSEcCtD
Buspirone—Myocardial infarction—Bleomycin—melanoma	0.000785	0.00495	CcSEcCtD
Buspirone—Influenza like illness—Docetaxel—melanoma	0.00078	0.00492	CcSEcCtD
Buspirone—Muscular weakness—Temozolomide—melanoma	0.000773	0.00487	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000768	0.00484	CcSEcCtD
Buspirone—Decreased appetite—Vemurafenib—melanoma	0.000733	0.00462	CcSEcCtD
Buspirone—Gastrointestinal disorder—Vemurafenib—melanoma	0.000728	0.00459	CcSEcCtD
Buspirone—Fatigue—Vemurafenib—melanoma	0.000727	0.00458	CcSEcCtD
Buspirone—Haemoglobin—Bleomycin—melanoma	0.000722	0.00455	CcSEcCtD
Buspirone—Constipation—Vemurafenib—melanoma	0.000721	0.00454	CcSEcCtD
Buspirone—Haemorrhage—Bleomycin—melanoma	0.000719	0.00453	CcSEcCtD
Buspirone—Lightheadedness—Docetaxel—melanoma	0.000718	0.00453	CcSEcCtD
Buspirone—Hypoaesthesia—Bleomycin—melanoma	0.000715	0.00451	CcSEcCtD
Buspirone—Dysuria—Temozolomide—melanoma	0.000708	0.00447	CcSEcCtD
Buspirone—Pollakiuria—Temozolomide—melanoma	0.0007	0.00441	CcSEcCtD
Buspirone—Erectile dysfunction—Temozolomide—melanoma	0.000698	0.0044	CcSEcCtD
Buspirone—Depression—Carmustine—melanoma	0.000697	0.00439	CcSEcCtD
Buspirone—Weight increased—Temozolomide—melanoma	0.000689	0.00435	CcSEcCtD
Buspirone—Weight decreased—Temozolomide—melanoma	0.000685	0.00432	CcSEcCtD
Buspirone—Depression—Temozolomide—melanoma	0.000673	0.00425	CcSEcCtD
Buspirone—Flushing—Bleomycin—melanoma	0.000667	0.00421	CcSEcCtD
Buspirone—Body temperature increased—Vemurafenib—melanoma	0.000666	0.0042	CcSEcCtD
Buspirone—Chills—Bleomycin—melanoma	0.000645	0.00407	CcSEcCtD
Buspirone—Cardiac failure congestive—Docetaxel—melanoma	0.000643	0.00405	CcSEcCtD
Buspirone—Alopecia—Bleomycin—melanoma	0.000635	0.004	CcSEcCtD
Buspirone—Haemoglobin—Carmustine—melanoma	0.00063	0.00398	CcSEcCtD
Buspirone—Haemorrhage—Carmustine—melanoma	0.000627	0.00396	CcSEcCtD
Buspirone—Erythema—Bleomycin—melanoma	0.000626	0.00394	CcSEcCtD
Buspirone—Hallucination—Carmustine—melanoma	0.000624	0.00394	CcSEcCtD
Buspirone—Hypoaesthesia—Carmustine—melanoma	0.000624	0.00394	CcSEcCtD
Buspirone—Flushing—Dactinomycin—melanoma	0.000622	0.00392	CcSEcCtD
Buspirone—Hypersensitivity—Vemurafenib—melanoma	0.000621	0.00391	CcSEcCtD
Buspirone—Dermatitis bullous—Docetaxel—melanoma	0.00061	0.00384	CcSEcCtD
Buspirone—Haemoglobin—Temozolomide—melanoma	0.000609	0.00384	CcSEcCtD
Buspirone—Haemorrhage—Temozolomide—melanoma	0.000606	0.00382	CcSEcCtD
Buspirone—Asthenia—Vemurafenib—melanoma	0.000605	0.00381	CcSEcCtD
Buspirone—Hallucination—Temozolomide—melanoma	0.000603	0.0038	CcSEcCtD
Buspirone—Hypoaesthesia—Temozolomide—melanoma	0.000603	0.0038	CcSEcCtD
Buspirone—Chills—Dactinomycin—melanoma	0.000601	0.00379	CcSEcCtD
Buspirone—Pruritus—Vemurafenib—melanoma	0.000596	0.00376	CcSEcCtD
Buspirone—Alopecia—Dactinomycin—melanoma	0.000592	0.00373	CcSEcCtD
Buspirone—Erythema—Dactinomycin—melanoma	0.000583	0.00368	CcSEcCtD
Buspirone—Flushing—Carmustine—melanoma	0.000582	0.00367	CcSEcCtD
Buspirone—Ill-defined disorder—Bleomycin—melanoma	0.00058	0.00366	CcSEcCtD
Buspirone—Diarrhoea—Vemurafenib—melanoma	0.000577	0.00364	CcSEcCtD
Buspirone—Tinnitus—Temozolomide—melanoma	0.000565	0.00356	CcSEcCtD
Buspirone—Malaise—Bleomycin—melanoma	0.000564	0.00356	CcSEcCtD
Buspirone—Flushing—Temozolomide—melanoma	0.000563	0.00355	CcSEcCtD
Buspirone—Leukopenia—Bleomycin—melanoma	0.00056	0.00353	CcSEcCtD
Buspirone—Dizziness—Vemurafenib—melanoma	0.000557	0.00351	CcSEcCtD
Buspirone—Alopecia—Carmustine—melanoma	0.000554	0.00349	CcSEcCtD
Buspirone—Ataxia—Docetaxel—melanoma	0.000548	0.00345	CcSEcCtD
Buspirone—Erythema—Carmustine—melanoma	0.000546	0.00344	CcSEcCtD
Buspirone—Chills—Temozolomide—melanoma	0.000544	0.00343	CcSEcCtD
Buspirone—Ill-defined disorder—Dactinomycin—melanoma	0.000541	0.00341	CcSEcCtD
Buspirone—Vomiting—Vemurafenib—melanoma	0.000536	0.00338	CcSEcCtD
Buspirone—Alopecia—Temozolomide—melanoma	0.000536	0.00338	CcSEcCtD
Buspirone—Dry skin—Docetaxel—melanoma	0.000534	0.00337	CcSEcCtD
Buspirone—Chest pain—Bleomycin—melanoma	0.000533	0.00336	CcSEcCtD
Buspirone—Myalgia—Bleomycin—melanoma	0.000533	0.00336	CcSEcCtD
Buspirone—Rash—Vemurafenib—melanoma	0.000531	0.00335	CcSEcCtD
Buspirone—Dermatitis—Vemurafenib—melanoma	0.000531	0.00335	CcSEcCtD
Buspirone—Headache—Vemurafenib—melanoma	0.000528	0.00333	CcSEcCtD
Buspirone—Erythema—Temozolomide—melanoma	0.000528	0.00333	CcSEcCtD
Buspirone—Discomfort—Bleomycin—melanoma	0.000526	0.00332	CcSEcCtD
Buspirone—Malaise—Dactinomycin—melanoma	0.000526	0.00332	CcSEcCtD
Buspirone—Cramp muscle—Docetaxel—melanoma	0.000525	0.00331	CcSEcCtD
Buspirone—Leukopenia—Dactinomycin—melanoma	0.000522	0.00329	CcSEcCtD
Buspirone—Dysgeusia—Temozolomide—melanoma	0.000517	0.00326	CcSEcCtD
Buspirone—Confusional state—Bleomycin—melanoma	0.000515	0.00325	CcSEcCtD
Buspirone—Vision blurred—Carmustine—melanoma	0.000515	0.00324	CcSEcCtD
Buspirone—Tremor—Carmustine—melanoma	0.000512	0.00323	CcSEcCtD
Buspirone—Oedema—Bleomycin—melanoma	0.000511	0.00322	CcSEcCtD
Buspirone—Agitation—Carmustine—melanoma	0.000502	0.00316	CcSEcCtD
Buspirone—Nausea—Vemurafenib—melanoma	0.000501	0.00316	CcSEcCtD
Buspirone—Thrombocytopenia—Bleomycin—melanoma	0.0005	0.00315	CcSEcCtD
Buspirone—Vision blurred—Temozolomide—melanoma	0.000497	0.00314	CcSEcCtD
Buspirone—Myalgia—Dactinomycin—melanoma	0.000497	0.00313	CcSEcCtD
Buspirone—Tremor—Temozolomide—melanoma	0.000494	0.00312	CcSEcCtD
Buspirone—Discomfort—Dactinomycin—melanoma	0.000491	0.00309	CcSEcCtD
Buspirone—Ill-defined disorder—Temozolomide—melanoma	0.00049	0.00309	CcSEcCtD
Buspirone—Leukopenia—Carmustine—melanoma	0.000489	0.00308	CcSEcCtD
Buspirone—Anorexia—Bleomycin—melanoma	0.000487	0.00307	CcSEcCtD
Buspirone—Agitation—Temozolomide—melanoma	0.000485	0.00306	CcSEcCtD
Buspirone—Angioedema—Temozolomide—melanoma	0.000482	0.00304	CcSEcCtD
Buspirone—Hypotension—Bleomycin—melanoma	0.000477	0.00301	CcSEcCtD
Buspirone—Oedema—Dactinomycin—melanoma	0.000476	0.003	CcSEcCtD
Buspirone—Malaise—Temozolomide—melanoma	0.000476	0.003	CcSEcCtD
Buspirone—Vertigo—Temozolomide—melanoma	0.000474	0.00299	CcSEcCtD
Buspirone—Convulsion—Carmustine—melanoma	0.000473	0.00298	CcSEcCtD
Buspirone—Leukopenia—Temozolomide—melanoma	0.000472	0.00298	CcSEcCtD
Buspirone—Hypertension—Carmustine—melanoma	0.000471	0.00297	CcSEcCtD
Buspirone—Palpitations—Temozolomide—melanoma	0.000466	0.00294	CcSEcCtD
Buspirone—Thrombocytopenia—Dactinomycin—melanoma	0.000466	0.00294	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000465	0.00293	CcSEcCtD
Buspirone—Chest pain—Carmustine—melanoma	0.000465	0.00293	CcSEcCtD
Buspirone—Myalgia—Carmustine—melanoma	0.000465	0.00293	CcSEcCtD
Buspirone—Paraesthesia—Bleomycin—melanoma	0.000458	0.00289	CcSEcCtD
Buspirone—Weight increased—Docetaxel—melanoma	0.000458	0.00289	CcSEcCtD
Buspirone—Convulsion—Temozolomide—melanoma	0.000457	0.00288	CcSEcCtD
Buspirone—Weight decreased—Docetaxel—melanoma	0.000456	0.00287	CcSEcCtD
Buspirone—Hypertension—Temozolomide—melanoma	0.000456	0.00287	CcSEcCtD
Buspirone—Dyspnoea—Bleomycin—melanoma	0.000455	0.00287	CcSEcCtD
Buspirone—Anorexia—Dactinomycin—melanoma	0.000454	0.00286	CcSEcCtD
Buspirone—Confusional state—Carmustine—melanoma	0.000449	0.00283	CcSEcCtD
Buspirone—Arthralgia—Temozolomide—melanoma	0.000449	0.00283	CcSEcCtD
Buspirone—Myalgia—Temozolomide—melanoma	0.000449	0.00283	CcSEcCtD
Buspirone—Oedema—Carmustine—melanoma	0.000446	0.00281	CcSEcCtD
Buspirone—Discomfort—Temozolomide—melanoma	0.000444	0.0028	CcSEcCtD
Buspirone—Decreased appetite—Bleomycin—melanoma	0.000444	0.0028	CcSEcCtD
Buspirone—Acute coronary syndrome—Docetaxel—melanoma	0.000443	0.00279	CcSEcCtD
Buspirone—Myocardial infarction—Docetaxel—melanoma	0.00044	0.00278	CcSEcCtD
Buspirone—Dry mouth—Temozolomide—melanoma	0.000439	0.00277	CcSEcCtD
Buspirone—Pain—Bleomycin—melanoma	0.000437	0.00275	CcSEcCtD
Buspirone—Conjunctivitis—Docetaxel—melanoma	0.000437	0.00275	CcSEcCtD
Buspirone—Thrombocytopenia—Carmustine—melanoma	0.000436	0.00275	CcSEcCtD
Buspirone—Tachycardia—Carmustine—melanoma	0.000435	0.00274	CcSEcCtD
Buspirone—Confusional state—Temozolomide—melanoma	0.000434	0.00274	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000434	0.00274	CcSEcCtD
Buspirone—Oedema—Temozolomide—melanoma	0.000431	0.00272	CcSEcCtD
Buspirone—Anorexia—Carmustine—melanoma	0.000425	0.00268	CcSEcCtD
Buspirone—Epistaxis—Docetaxel—melanoma	0.000424	0.00267	CcSEcCtD
Buspirone—Thrombocytopenia—Temozolomide—melanoma	0.000422	0.00266	CcSEcCtD
Buspirone—Feeling abnormal—Bleomycin—melanoma	0.000421	0.00265	CcSEcCtD
Buspirone—Hypotension—Carmustine—melanoma	0.000416	0.00263	CcSEcCtD
Buspirone—Hyperhidrosis—Temozolomide—melanoma	0.000416	0.00263	CcSEcCtD
Buspirone—Decreased appetite—Dactinomycin—melanoma	0.000414	0.00261	CcSEcCtD
Buspirone—Fatigue—Dactinomycin—melanoma	0.000411	0.00259	CcSEcCtD
Buspirone—Anorexia—Temozolomide—melanoma	0.000411	0.00259	CcSEcCtD
Buspirone—Pain—Dactinomycin—melanoma	0.000407	0.00257	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Carmustine—melanoma	0.000406	0.00256	CcSEcCtD
Buspirone—Urticaria—Bleomycin—melanoma	0.000406	0.00256	CcSEcCtD
Buspirone—Haemoglobin—Docetaxel—melanoma	0.000405	0.00255	CcSEcCtD
Buspirone—Body temperature increased—Bleomycin—melanoma	0.000404	0.00254	CcSEcCtD
Buspirone—Haemorrhage—Docetaxel—melanoma	0.000403	0.00254	CcSEcCtD
Buspirone—Insomnia—Carmustine—melanoma	0.000403	0.00254	CcSEcCtD
Buspirone—Hypoaesthesia—Docetaxel—melanoma	0.000401	0.00253	CcSEcCtD
Buspirone—Paraesthesia—Carmustine—melanoma	0.0004	0.00252	CcSEcCtD
Buspirone—Dyspnoea—Carmustine—melanoma	0.000397	0.00251	CcSEcCtD
Buspirone—Somnolence—Carmustine—melanoma	0.000396	0.0025	CcSEcCtD
Buspirone—Feeling abnormal—Dactinomycin—melanoma	0.000392	0.00247	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000392	0.00247	CcSEcCtD
Buspirone—Insomnia—Temozolomide—melanoma	0.00039	0.00246	CcSEcCtD
Buspirone—Decreased appetite—Carmustine—melanoma	0.000387	0.00244	CcSEcCtD
Buspirone—Paraesthesia—Temozolomide—melanoma	0.000387	0.00244	CcSEcCtD
Buspirone—Gastrointestinal disorder—Carmustine—melanoma	0.000385	0.00243	CcSEcCtD
Buspirone—Dyspnoea—Temozolomide—melanoma	0.000384	0.00242	CcSEcCtD
Buspirone—Somnolence—Temozolomide—melanoma	0.000383	0.00241	CcSEcCtD
Buspirone—Pain—Carmustine—melanoma	0.000381	0.0024	CcSEcCtD
Buspirone—Constipation—Carmustine—melanoma	0.000381	0.0024	CcSEcCtD
Buspirone—Dyspepsia—Temozolomide—melanoma	0.000379	0.00239	CcSEcCtD
Buspirone—Body temperature increased—Dactinomycin—melanoma	0.000376	0.00237	CcSEcCtD
Buspirone—Hypersensitivity—Bleomycin—melanoma	0.000376	0.00237	CcSEcCtD
Buspirone—Decreased appetite—Temozolomide—melanoma	0.000374	0.00236	CcSEcCtD
Buspirone—Flushing—Docetaxel—melanoma	0.000374	0.00236	CcSEcCtD
Buspirone—Gastrointestinal disorder—Temozolomide—melanoma	0.000372	0.00234	CcSEcCtD
Buspirone—Fatigue—Temozolomide—melanoma	0.000371	0.00234	CcSEcCtD
Buspirone—Pain—Temozolomide—melanoma	0.000368	0.00232	CcSEcCtD
Buspirone—Constipation—Temozolomide—melanoma	0.000368	0.00232	CcSEcCtD
Buspirone—Feeling abnormal—Carmustine—melanoma	0.000367	0.00232	CcSEcCtD
Buspirone—Asthenia—Bleomycin—melanoma	0.000366	0.00231	CcSEcCtD
Buspirone—Chills—Docetaxel—melanoma	0.000362	0.00228	CcSEcCtD
Buspirone—Pruritus—Bleomycin—melanoma	0.000361	0.00228	CcSEcCtD
Buspirone—Alopecia—Docetaxel—melanoma	0.000356	0.00225	CcSEcCtD
Buspirone—Feeling abnormal—Temozolomide—melanoma	0.000355	0.00224	CcSEcCtD
Buspirone—Body temperature increased—Carmustine—melanoma	0.000352	0.00222	CcSEcCtD
Buspirone—Erythema—Docetaxel—melanoma	0.000351	0.00221	CcSEcCtD
Buspirone—Hypersensitivity—Dactinomycin—melanoma	0.000351	0.00221	CcSEcCtD
Buspirone—Dysgeusia—Docetaxel—melanoma	0.000344	0.00217	CcSEcCtD
Buspirone—Urticaria—Temozolomide—melanoma	0.000342	0.00216	CcSEcCtD
Buspirone—Asthenia—Dactinomycin—melanoma	0.000342	0.00215	CcSEcCtD
Buspirone—Body temperature increased—Temozolomide—melanoma	0.00034	0.00215	CcSEcCtD
Buspirone—Muscle spasms—Docetaxel—melanoma	0.000337	0.00213	CcSEcCtD
Buspirone—Hypersensitivity—Carmustine—melanoma	0.000328	0.00207	CcSEcCtD
Buspirone—Diarrhoea—Dactinomycin—melanoma	0.000326	0.00205	CcSEcCtD
Buspirone—Vomiting—Bleomycin—melanoma	0.000325	0.00205	CcSEcCtD
Buspirone—Rash—Bleomycin—melanoma	0.000322	0.00203	CcSEcCtD
Buspirone—Dermatitis—Bleomycin—melanoma	0.000322	0.00203	CcSEcCtD
Buspirone—Asthenia—Carmustine—melanoma	0.00032	0.00202	CcSEcCtD
Buspirone—Hypersensitivity—Temozolomide—melanoma	0.000317	0.002	CcSEcCtD
Buspirone—Syncope—Docetaxel—melanoma	0.000315	0.00198	CcSEcCtD
Buspirone—Leukopenia—Docetaxel—melanoma	0.000314	0.00198	CcSEcCtD
Buspirone—Palpitations—Docetaxel—melanoma	0.00031	0.00196	CcSEcCtD
Buspirone—Asthenia—Temozolomide—melanoma	0.000309	0.00195	CcSEcCtD
Buspirone—Loss of consciousness—Docetaxel—melanoma	0.000308	0.00194	CcSEcCtD
Buspirone—Diarrhoea—Carmustine—melanoma	0.000305	0.00192	CcSEcCtD
Buspirone—Pruritus—Temozolomide—melanoma	0.000305	0.00192	CcSEcCtD
Buspirone—Convulsion—Docetaxel—melanoma	0.000304	0.00192	CcSEcCtD
Buspirone—Nausea—Bleomycin—melanoma	0.000303	0.00191	CcSEcCtD
Buspirone—Hypertension—Docetaxel—melanoma	0.000303	0.00191	CcSEcCtD
Buspirone—Vomiting—Dactinomycin—melanoma	0.000303	0.00191	CcSEcCtD
Buspirone—Rash—Dactinomycin—melanoma	0.0003	0.00189	CcSEcCtD
Buspirone—Arthralgia—Docetaxel—melanoma	0.000299	0.00188	CcSEcCtD
Buspirone—Chest pain—Docetaxel—melanoma	0.000299	0.00188	CcSEcCtD
Buspirone—Myalgia—Docetaxel—melanoma	0.000299	0.00188	CcSEcCtD
Buspirone—Dizziness—Carmustine—melanoma	0.000295	0.00186	CcSEcCtD
Buspirone—Diarrhoea—Temozolomide—melanoma	0.000295	0.00186	CcSEcCtD
Buspirone—Dry mouth—Docetaxel—melanoma	0.000292	0.00184	CcSEcCtD
Buspirone—Confusional state—Docetaxel—melanoma	0.000289	0.00182	CcSEcCtD
Buspirone—Oedema—Docetaxel—melanoma	0.000286	0.00181	CcSEcCtD
Buspirone—Dizziness—Temozolomide—melanoma	0.000285	0.0018	CcSEcCtD
Buspirone—Vomiting—Carmustine—melanoma	0.000283	0.00179	CcSEcCtD
Buspirone—Nausea—Dactinomycin—melanoma	0.000283	0.00178	CcSEcCtD
Buspirone—Shock—Docetaxel—melanoma	0.000282	0.00178	CcSEcCtD
Buspirone—Rash—Carmustine—melanoma	0.000281	0.00177	CcSEcCtD
Buspirone—Dermatitis—Carmustine—melanoma	0.000281	0.00177	CcSEcCtD
Buspirone—Thrombocytopenia—Docetaxel—melanoma	0.00028	0.00177	CcSEcCtD
Buspirone—Tachycardia—Docetaxel—melanoma	0.00028	0.00176	CcSEcCtD
Buspirone—Headache—Carmustine—melanoma	0.000279	0.00176	CcSEcCtD
Buspirone—Vomiting—Temozolomide—melanoma	0.000274	0.00173	CcSEcCtD
Buspirone—Anorexia—Docetaxel—melanoma	0.000273	0.00172	CcSEcCtD
Buspirone—Rash—Temozolomide—melanoma	0.000272	0.00171	CcSEcCtD
Buspirone—Dermatitis—Temozolomide—melanoma	0.000271	0.00171	CcSEcCtD
Buspirone—Headache—Temozolomide—melanoma	0.00027	0.0017	CcSEcCtD
Buspirone—Hypotension—Docetaxel—melanoma	0.000268	0.00169	CcSEcCtD
Buspirone—Nausea—Carmustine—melanoma	0.000265	0.00167	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000261	0.00165	CcSEcCtD
Buspirone—Insomnia—Docetaxel—melanoma	0.000259	0.00163	CcSEcCtD
Buspirone—Paraesthesia—Docetaxel—melanoma	0.000257	0.00162	CcSEcCtD
Buspirone—Nausea—Temozolomide—melanoma	0.000256	0.00161	CcSEcCtD
Buspirone—Dyspnoea—Docetaxel—melanoma	0.000255	0.00161	CcSEcCtD
Buspirone—Somnolence—Docetaxel—melanoma	0.000255	0.00161	CcSEcCtD
Buspirone—Dyspepsia—Docetaxel—melanoma	0.000252	0.00159	CcSEcCtD
Buspirone—Decreased appetite—Docetaxel—melanoma	0.000249	0.00157	CcSEcCtD
Buspirone—Gastrointestinal disorder—Docetaxel—melanoma	0.000247	0.00156	CcSEcCtD
Buspirone—Fatigue—Docetaxel—melanoma	0.000247	0.00156	CcSEcCtD
Buspirone—Constipation—Docetaxel—melanoma	0.000245	0.00154	CcSEcCtD
Buspirone—Pain—Docetaxel—melanoma	0.000245	0.00154	CcSEcCtD
Buspirone—Feeling abnormal—Docetaxel—melanoma	0.000236	0.00149	CcSEcCtD
Buspirone—Body temperature increased—Docetaxel—melanoma	0.000226	0.00143	CcSEcCtD
Buspirone—Hypersensitivity—Docetaxel—melanoma	0.000211	0.00133	CcSEcCtD
Buspirone—Asthenia—Docetaxel—melanoma	0.000205	0.0013	CcSEcCtD
Buspirone—Pruritus—Docetaxel—melanoma	0.000203	0.00128	CcSEcCtD
Buspirone—Diarrhoea—Docetaxel—melanoma	0.000196	0.00124	CcSEcCtD
Buspirone—Dizziness—Docetaxel—melanoma	0.000189	0.00119	CcSEcCtD
Buspirone—Vomiting—Docetaxel—melanoma	0.000182	0.00115	CcSEcCtD
Buspirone—Rash—Docetaxel—melanoma	0.000181	0.00114	CcSEcCtD
Buspirone—Dermatitis—Docetaxel—melanoma	0.00018	0.00114	CcSEcCtD
Buspirone—Headache—Docetaxel—melanoma	0.000179	0.00113	CcSEcCtD
Buspirone—Nausea—Docetaxel—melanoma	0.00017	0.00107	CcSEcCtD
Buspirone—HTR1A—Signaling Pathways—IGF1—melanoma	9.64e-06	9.49e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PIK3CB—melanoma	9.61e-06	9.46e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—MAPK1—melanoma	9.59e-06	9.44e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—EGFR—melanoma	9.59e-06	9.44e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CXCL8—melanoma	9.56e-06	9.41e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—PIK3CA—melanoma	9.55e-06	9.4e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTGS2—melanoma	9.53e-06	9.38e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MDM2—melanoma	9.51e-06	9.36e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—FN1—melanoma	9.5e-06	9.35e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—HRAS—melanoma	9.5e-06	9.35e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NOTCH1—melanoma	9.45e-06	9.3e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—ERBB2—melanoma	9.38e-06	9.23e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CDKN1B—melanoma	9.34e-06	9.19e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MAP2K1—melanoma	9.32e-06	9.17e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NOTCH1—melanoma	9.3e-06	9.15e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CD80—melanoma	9.26e-06	9.11e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CB—melanoma	9.26e-06	9.11e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CD—melanoma	9.26e-06	9.11e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—APC—melanoma	9.24e-06	9.1e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—KIT—melanoma	9.24e-06	9.1e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CG—melanoma	9.24e-06	9.1e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—NRAS—melanoma	9.24e-06	9.1e-05	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—AKT1—melanoma	9.24e-06	9.09e-05	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—PIK3CA—melanoma	9.17e-06	9.02e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CASP3—melanoma	9.15e-06	9.01e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EGF—melanoma	9.14e-06	8.99e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IL2—melanoma	9.14e-06	8.99e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CD80—melanoma	9.11e-06	8.97e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CG—melanoma	9.1e-06	8.95e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KIT—melanoma	9.1e-06	8.95e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—APC—melanoma	9.1e-06	8.95e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—NRAS—melanoma	9.1e-06	8.95e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—IL6—melanoma	9.09e-06	8.95e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CG—melanoma	9.07e-06	8.93e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—KRAS—melanoma	9.06e-06	8.92e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EGF—melanoma	8.99e-06	8.85e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ABCB1—melanoma	8.95e-06	8.8e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CCND1—melanoma	8.91e-06	8.77e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CXCL8—melanoma	8.9e-06	8.76e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—FGF2—melanoma	8.86e-06	8.72e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—MAPK3—melanoma	8.85e-06	8.71e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—HRAS—melanoma	8.84e-06	8.7e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CTNNB1—melanoma	8.82e-06	8.68e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PPARG—melanoma	8.75e-06	8.61e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PRKCA—melanoma	8.74e-06	8.6e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—MAPK3—melanoma	8.71e-06	8.57e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—BRAF—melanoma	8.69e-06	8.55e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CDKN1B—melanoma	8.69e-06	8.55e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ERCC2—melanoma	8.67e-06	8.53e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MMP9—melanoma	8.65e-06	8.51e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CDKN1A—melanoma	8.62e-06	8.48e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PTEN—melanoma	8.6e-06	8.46e-05	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—AKT1—melanoma	8.59e-06	8.46e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NFKB1—melanoma	8.56e-06	8.42e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—BRAF—melanoma	8.55e-06	8.41e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CASP3—melanoma	8.51e-06	8.38e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL2—melanoma	8.5e-06	8.37e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IGF1—melanoma	8.46e-06	8.33e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—IL6—melanoma	8.46e-06	8.33e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP17A1—melanoma	8.44e-06	8.31e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—MAPK1—melanoma	8.42e-06	8.29e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—EGFR—melanoma	8.42e-06	8.29e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—AKT1—melanoma	8.39e-06	8.25e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IGF1—melanoma	8.33e-06	8.2e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—PIK3CA—melanoma	8.33e-06	8.19e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTEN—melanoma	8.31e-06	8.18e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MDM2—melanoma	8.29e-06	8.16e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—MAPK1—melanoma	8.29e-06	8.16e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CCND1—melanoma	8.29e-06	8.16e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—EGFR—melanoma	8.29e-06	8.16e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PRKCA—melanoma	8.23e-06	8.1e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CTNNB1—melanoma	8.21e-06	8.08e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAP2K1—melanoma	8.18e-06	8.05e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ERBB2—melanoma	8.18e-06	8.05e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ERCC2—melanoma	8.17e-06	8.04e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CD—melanoma	8.13e-06	8e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CB—melanoma	8.07e-06	7.94e-05	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—PIK3CA—melanoma	8.05e-06	7.92e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAP2K1—melanoma	8.05e-06	7.92e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MMP9—melanoma	8.05e-06	7.92e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CDKN1A—melanoma	8.02e-06	7.89e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PTEN—melanoma	8e-06	7.87e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CD—melanoma	8e-06	7.87e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CD—melanoma	7.97e-06	7.85e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GNA11—melanoma	7.97e-06	7.84e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NFKB1—melanoma	7.96e-06	7.83e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—KRAS—melanoma	7.96e-06	7.83e-05	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—PIK3CA—melanoma	7.92e-06	7.8e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ALB—melanoma	7.87e-06	7.75e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—KRAS—melanoma	7.83e-06	7.7e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—AKT1—melanoma	7.8e-06	7.68e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—FASN—melanoma	7.8e-06	7.68e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—FGF2—melanoma	7.78e-06	7.66e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—VEGFA—melanoma	7.76e-06	7.64e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CXCL8—melanoma	7.75e-06	7.63e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—HRAS—melanoma	7.7e-06	7.58e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—STAT3—melanoma	7.69e-06	7.57e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SLC5A5—melanoma	7.67e-06	7.55e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NRAS—melanoma	7.67e-06	7.55e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—FGF2—melanoma	7.66e-06	7.54e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CDKN1B—melanoma	7.57e-06	7.45e-05	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—AKT1—melanoma	7.49e-06	7.37e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CASP3—melanoma	7.42e-06	7.3e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL2—melanoma	7.41e-06	7.29e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GNAQ—melanoma	7.41e-06	7.29e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CD44—melanoma	7.41e-06	7.29e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—IL6—melanoma	7.37e-06	7.26e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MAPK3—melanoma	7.35e-06	7.23e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—PIK3CA—melanoma	7.31e-06	7.19e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MDM2—melanoma	7.28e-06	7.17e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—VEGFA—melanoma	7.22e-06	7.11e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CCND1—melanoma	7.22e-06	7.11e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—PIK3CA—melanoma	7.19e-06	7.08e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ERBB2—melanoma	7.18e-06	7.06e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MDM2—melanoma	7.16e-06	7.05e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—STAT3—melanoma	7.15e-06	7.04e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CTNNB1—melanoma	7.15e-06	7.04e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MYC—melanoma	7.14e-06	7.03e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NRAS—melanoma	7.14e-06	7.02e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP1B1—melanoma	7.1e-06	6.99e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CB—melanoma	7.08e-06	6.97e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ERBB2—melanoma	7.06e-06	6.95e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MMP9—melanoma	7.01e-06	6.9e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MAPK1—melanoma	6.99e-06	6.88e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EGFR—melanoma	6.99e-06	6.88e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CDKN1A—melanoma	6.99e-06	6.88e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PTEN—melanoma	6.97e-06	6.86e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CB—melanoma	6.97e-06	6.86e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CB—melanoma	6.95e-06	6.84e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NFKB1—melanoma	6.94e-06	6.83e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTGS2—melanoma	6.89e-06	6.78e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CG—melanoma	6.84e-06	6.74e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MAPK3—melanoma	6.83e-06	6.73e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CXCL8—melanoma	6.81e-06	6.7e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—AKT1—melanoma	6.8e-06	6.69e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—HRAS—melanoma	6.76e-06	6.66e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CXCL8—melanoma	6.7e-06	6.59e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—HRAS—melanoma	6.65e-06	6.55e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CDKN1B—melanoma	6.65e-06	6.54e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MYC—melanoma	6.65e-06	6.54e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PPARG—melanoma	6.6e-06	6.5e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—KRAS—melanoma	6.6e-06	6.5e-05	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—AKT1—melanoma	6.58e-06	6.47e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CDKN1B—melanoma	6.54e-06	6.44e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CASP3—melanoma	6.52e-06	6.41e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL2—melanoma	6.51e-06	6.4e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MAPK1—melanoma	6.5e-06	6.4e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EGFR—melanoma	6.5e-06	6.4e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—IL6—melanoma	6.47e-06	6.37e-05	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—AKT1—melanoma	6.47e-06	6.37e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CG—melanoma	6.45e-06	6.35e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CASP3—melanoma	6.41e-06	6.31e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL2—melanoma	6.4e-06	6.3e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—IL6—melanoma	6.37e-06	6.27e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CCND1—melanoma	6.34e-06	6.24e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—VEGFA—melanoma	6.3e-06	6.2e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CTNNB1—melanoma	6.28e-06	6.18e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CCND1—melanoma	6.24e-06	6.14e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—STAT3—melanoma	6.23e-06	6.14e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PPARG—melanoma	6.22e-06	6.13e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NRAS—melanoma	6.22e-06	6.12e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CTNNB1—melanoma	6.18e-06	6.08e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MMP9—melanoma	6.16e-06	6.06e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—KRAS—melanoma	6.14e-06	6.05e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CDKN1A—melanoma	6.13e-06	6.04e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PTEN—melanoma	6.12e-06	6.02e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NFKB1—melanoma	6.09e-06	6e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PIK3CA—melanoma	6.06e-06	5.97e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MMP9—melanoma	6.06e-06	5.96e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CDKN1A—melanoma	6.04e-06	5.94e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PTEN—melanoma	6.02e-06	5.93e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CD—melanoma	6.02e-06	5.92e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTEN—melanoma	6e-06	5.91e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NFKB1—melanoma	5.99e-06	5.9e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—AKT1—melanoma	5.97e-06	5.88e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MAPK3—melanoma	5.96e-06	5.86e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ALB—melanoma	5.94e-06	5.85e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—AKT1—melanoma	5.88e-06	5.78e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TP53—melanoma	5.87e-06	5.77e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PIK3CA—melanoma	5.86e-06	5.77e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ABCB1—melanoma	5.85e-06	5.76e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MYC—melanoma	5.79e-06	5.7e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CD—melanoma	5.67e-06	5.58e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MAPK1—melanoma	5.67e-06	5.58e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EGFR—melanoma	5.67e-06	5.58e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CA—melanoma	5.64e-06	5.55e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HRAS—melanoma	5.61e-06	5.52e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ALB—melanoma	5.6e-06	5.51e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—VEGFA—melanoma	5.53e-06	5.44e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—STAT3—melanoma	5.47e-06	5.39e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NRAS—melanoma	5.46e-06	5.37e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TP53—melanoma	5.46e-06	5.37e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—VEGFA—melanoma	5.44e-06	5.35e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—STAT3—melanoma	5.39e-06	5.3e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PRKCA—melanoma	5.38e-06	5.3e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NRAS—melanoma	5.37e-06	5.29e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IL6—melanoma	5.37e-06	5.29e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—KRAS—melanoma	5.35e-06	5.27e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ERCC2—melanoma	5.34e-06	5.25e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CB—melanoma	5.24e-06	5.16e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAPK3—melanoma	5.23e-06	5.15e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HRAS—melanoma	5.22e-06	5.14e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTGS2—melanoma	5.2e-06	5.11e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAPK3—melanoma	5.15e-06	5.06e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MYC—melanoma	5.09e-06	5.01e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MYC—melanoma	5.01e-06	4.93e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL6—melanoma	5e-06	4.92e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAPK1—melanoma	4.98e-06	4.9e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EGFR—melanoma	4.98e-06	4.9e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—AKT1—melanoma	4.95e-06	4.88e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CB—melanoma	4.94e-06	4.86e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CA—melanoma	4.92e-06	4.84e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAPK1—melanoma	4.9e-06	4.82e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTGS2—melanoma	4.9e-06	4.82e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EGFR—melanoma	4.9e-06	4.82e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—AKT1—melanoma	4.79e-06	4.71e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TP53—melanoma	4.76e-06	4.68e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—KRAS—melanoma	4.7e-06	4.63e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KRAS—melanoma	4.62e-06	4.55e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—AKT1—melanoma	4.61e-06	4.54e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HRAS—melanoma	4.55e-06	4.48e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTEN—melanoma	4.53e-06	4.46e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL6—melanoma	4.35e-06	4.29e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CA—melanoma	4.32e-06	4.25e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTEN—melanoma	4.27e-06	4.2e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CA—melanoma	4.25e-06	4.18e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CA—melanoma	4.24e-06	4.17e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CG—melanoma	4.22e-06	4.15e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TP53—melanoma	4.18e-06	4.11e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TP53—melanoma	4.11e-06	4.05e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PPARG—melanoma	4.07e-06	4.01e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—AKT1—melanoma	4.02e-06	3.95e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HRAS—melanoma	4e-06	3.93e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HRAS—melanoma	3.93e-06	3.87e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL6—melanoma	3.82e-06	3.76e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL6—melanoma	3.76e-06	3.7e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CD—melanoma	3.71e-06	3.65e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ALB—melanoma	3.66e-06	3.6e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—AKT1—melanoma	3.53e-06	3.47e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—AKT1—melanoma	3.47e-06	3.42e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—AKT1—melanoma	3.46e-06	3.41e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CB—melanoma	3.23e-06	3.18e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTGS2—melanoma	3.2e-06	3.15e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CA—melanoma	3.2e-06	3.15e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CA—melanoma	3.01e-06	2.96e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTEN—melanoma	2.79e-06	2.75e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—AKT1—melanoma	2.61e-06	2.57e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—AKT1—melanoma	2.46e-06	2.42e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CA—melanoma	1.97e-06	1.94e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—AKT1—melanoma	1.61e-06	1.58e-05	CbGpPWpGaD
